NEW YORK (GenomeWeb) – Roche today reported a 9 percent year-over-year increase in sales for molecular diagnostics in the first half of 2015, driven by strong growth in its underlying molecular businesses and its sequencing products sales.

The Swiss pharma and diagnostics firm reported overall sales of CHF 23.59 billion ($24.63 billion) for the period, a 3 percent increase over sales of CHF 22.98 billion reported for the first half of 2014. Revenues increased 6 percent at constant exchange rates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.